News

The Siberian Ginseng (Acanthopanax) Polysaccharide is extracted from the stem of Siberian Ginseng by proprietary extraction technology separating and extracting effective parts of the Siberian Ginseng. The powder

The 18-month randomized, parallel group, double-blind, placebo-controlled trial conducted in 512 ALS patients evaluated the efficacy and safety of olesoxime against placebo in patients treated with riluzole. Olesoxime

Kun Tuo will lay emphasis on the development of customized solutions to help local and global biopharma companies achieve registration of new medicines in China. In addition the

Under the deal, Megapharm will seek regulatory approval for Fanapt, and Vanda will supply Megapharm with Fanapt drug product for packaging and sale in Israel. Vanda CEO Mihael

MedPodium’s Nutra-Apps are small, pharmaceutically-sealed, tasteless, easy-use capsules in pocket-sized packaging, designed to promote personal health. The Neo-Energy product is a dietary supplement capsule without any sugar, calories,

The company claims that once developed and approved, ITCA 650 would be the first and only once-yearly injection-free GLP-1 therapy for the treatment of Type 2 diabetes that

Utilizing a novel technology called Particle Replication In Non-Wetting Templates (PRINT) platform, Liquidia is developing rationally designed carriers for improved delivery of small molecule and biological cargos. Liquidia

The initiative follows a formal pre-NDA verification with the FDA that verified the results from Tarsa’s Phase III ORACAL trial and the requirements for regulatory approval. The Phase

The funds will be used for the preclinical development of m102.4, an antibody indicated as a post-exposure prophylactic against Nipah or Hendra virus infection, that can lead to